Add to Favorites Newsroom RSS Share
fb-shareRutgers Cancer Institute of New Jersey
New Brunswick, NJ USA

Our News on Newswise


Lymph Node Removal Procedure as First-Line Treatment for Testicular Seminoma Associated with Favorable Survival Rates

Investigators at Rutgers Cancer Institute of New Jersey have found that a surgical procedure, when used as a first-line therapy for a form of testicular cancer known as seminoma, is associated with favorable survival rates.
12-Feb-2019 11:05 AM EST Add to Favorites


Targeting an ‘Energy Crisis’ in the Treatment of Non-Small Cell Lung Cancer

Research from Rutgers Cancer Institute of New Jersey examined a potential approach to cancer therapy that disrupts a cancer cell’s ‘fuel supply’ by targeting a cellular survival mechanism known as autophagy. Using laboratory models for...
25-Jan-2019 1:00 PM EST Add to Favorites


Exploring Targeted Therapy for Non-Small Cell Lung Cancer

Rutgers Cancer Institute of New Jersey researcher Sharon R. Pine, PhD, has received a $200,000 Lung Cancer Discovery Award from the American Lung Association to examine potential new treatment options for patients with a sub-type of non-small cell...
24-Jan-2019 12:00 PM EST Add to Favorites


Solid Tumor Genomic Sequencing can Reveal Coexistent Hematologic Malignancy

Investigators at Rutgers Cancer Institute have uncovered that some mutations detected with targeted genome sequencing of patients with solid tumors are a result of a group of hematologic malignancies known as myeloproliferative neoplasms (MPN). This...
2-Jan-2019 11:00 AM EST Add to Favorites


Improved Overall Survival Shown in Pediatric Hodgkin Lymphoma Patients when Receiving Combined Modality Treatment

Research from Rutgers Cancer Institute of New Jersey shows improved overall survival at five years for pediatric patients with early-stage Hodgkin lymphoma when treated with chemotherapy followed by radiotherapy versus chemotherapy alone.
2-Jan-2019 11:00 AM EST Add to Favorites


A Resolution for Good Health

Rutgers Cancer Institute experts share more about the importance of preventative screenings for colorectal and lung cancers.
26-Dec-2018 10:35 AM EST Add to Favorites


An Online Intervention to Reduce Skin Cancer in Young Adults

Rutgers Cancer Institute of New Jersey is leading a research study aimed at improving skin cancer protection behaviors in young adults through an online intervention.
17-Dec-2018 3:05 PM EST Add to Favorites


Exploring Clinical Activity of an Immunotherapy Drug that Targets Lymphomas

An investigational immunotherapy drug has demonstrated efficacy and an acceptable safety profile in the treatment of follicular lymphoma, diffuse large B-cell lymphoma and other B cell non-Hodgkin lymphoma subtypes. The lead investigator from...
29-Nov-2018 2:05 PM EST Add to Favorites

see all news

Our Experts on Newswise


A New Tool to Help Fight an Old Enemy – Lung Cancer

In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT


September is Sickle Cell Disease Awareness Month

Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT


Thyroid Cancer 101

While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT


Ovarian Cancer: What You Need to Know

During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT


Prostate Cancer PSA Screening: Finding Clarity in Confusion

With recent changes in recommendations for PSA testing for prostate cancer, confusion may exist for those considering the screening. A Rutgers Cancer Institute of New Jersey expert shares what one needs to know when discussing the topic with his...
13-Sep-2018 8:05 AM EDT


Palliative Care: Another Level of Support in the Cancer Journey

With word this week that former PGA Tour golfer Jarrod Lyle is transitioning from treatment for acute myeloid leukemia to palliative care, one might wonder what that form of care entails. A Rutgers Cancer Institute of New Jersey expert shares more...
1-Aug-2018 7:05 AM EDT


Checking in (and Checking up) on Dad this Father’s Day

Instead of another tie or tools, give the gift of good health this Father’s Day. As Rutgers Cancer Institute of New Jersey experts note, it’s as simple as encouraging regular health screenings to protect against cancer.
14-Jun-2018 4:05 PM EDT


Sun Safety: Planning is Your Best Protection

Longer days means more exposure to the sun and harmful UV rays. A Rutgers Cancer Institute of New Jersey expert shares some tips on how to keep your skin safe this season and all year long.
24-May-2018 9:20 AM EDT

see all experts

Our YouTube Videos


As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the transformation of laboratory discoveries into clinical practice. Rutgers Cancer Institute of New Jersey delivers advanced comprehensive care to adults and children including access to clinical trials and conducts cutting-edge cancer research.

The coveted NCI designation, awarded to only 47 such centers nationwide, is granted competitively to institutions characterized by scientific excellence and the ability to bring research discoveries to patients. To gain a "comprehensive" designation, the highest ranking given by the NCI, a center must meet rigorous criteria in cancer care, research, prevention and education.

The leadership of Rutgers Cancer Institute is comprised of distinguished researchers and physicians who are internationally recognized in their field. Basic scientists, clinical researchers, and population scientists meet regularly to exchange information and ensure that laboratory discoveries are refined and applied to clinical care as quickly as possible, that clinical observations reach laboratory researchers on a continuing basis, and that prevention strategies are interwoven in to all research programs.


No experts available.


Main Box
Program Assistant


Sue Caputo
Program Assistant


Michele Fisher
Public Relations Manager


Twitter twitter-icon

Chat now!